TaurelFinance, decoded
Live
Loading market data…
TTaurel

Heart drug developer Kardigan targets $1.4 billion valuation in US IPO

Investing.com· Reuters· Jun 11, 2026 · 12:12 PM
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO

This is a summary. Read the complete story at Investing.com below.

Read full article at Investing.com

Related Stories

Why is Albemarle stock climbing today?
stocksabout 1 hour ago

Why is Albemarle stock climbing today?

Investing.com

Evonik to cut 3,200 jobs globally through 2029
stocksabout 1 hour ago

Evonik to cut 3,200 jobs globally through 2029

Investing.com

Why is Intertek stock rallying today?
stocksabout 1 hour ago

Why is Intertek stock rallying today?

Investing.com